Weill Cornell Medicine Pathology and Laboratory Medicine

“The findings provide the first evidence that a non inhaled, metal-free carbon monoxide can suppress in multiple models,” said our colleague Dr. Nancy Du on her new paper in the journal Advanced Science.

Metal-free carbon monoxide treatment may help prevent cancer’s deadly spread | Cornell Chronicle A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.

Our colleage Dr. Anna Nam () has been selected as a Pew-Stewart Scholar for Cancer Research!

Dr. Nam is investigating the genetic determinants that influence the clinical manifestations of .

https://impact.weill.cornell.edu/summer-2026/notable/news-briefs

Congrats to our colleague Dr. Matthew Greenblatt on earning the prestigious Paul-Gallin Trailblazer Prize for Physician-Scientists for the discovery that bone contains multiple populations of stem cells with different anatomic locations and functions!

https://impact.weill.cornell.edu/summer-2026/notable/news-briefs

We hope you can join us!

One week from today!

Our department's Chief of Neuropathology, Dr. David Pisapia, will present a Meyer Cancer Center virtual session "Center for Translational ," on May 19th at noon!

Register today!

Congratulations to our colleague Dr. Jesus Delgado De La Mora (below left) on earning the 2026 Award for Best Poster in Anatomic Pathology during this week's Pathology Trainee Research Day, with Drs. Juan Miguel Mosquera and Eda Nur Kozan (below right)!

How cool is this!

Our colleague Dr. Supram Subramanya from the Clinical Microbiology Lab won our Trainee Research Day Award for Best Pathology Art entitled "Spring on Agar."

This artwork was created by cultivating naturally pigmented bacteria and yeast on agar in the lab, with selective use of chromogenic media and light staining to enhance color and contrast.

Please share:

The WCM Pathology and Laboratory Medicine department in New York City offers a one-year ACGME-approved Hematopathology Fellowship for 2027-28 under the directorship of Dr. Sanjay Patel!

Learn more and apply today:
https://www.society-for-hematopathology.org/web/job-board-details.php?id=305

Dr. Ethel Cesarman of our team has defined new transcriptional and functional characteristics of Hodgkin and Reed-Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL), detailing how malignant cells are the result of an arrested stage of B cell development.

The research, published Blood Cancer Journal, shows that characteristics of HRS cells are incomplete plasma cell differentiation, robust unfolded protein response (UPR) activation, and coordinated immune evasion mechanisms that influence both T cells and natural killer (NK) cells.

Read the Inside Precision Medicine coverage of this important finding:

Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition Characteristics of HRS cells are incomplete plasma cell differentiation, robust unfolded protein response (UPR) activation, and coordinated immune evasion mechanisms that influence both T cells and natural killer (NK) cells.

Please join us in congratulating our 2026-2027 Incoming Pathology Fellows!